Antiplatelet therapy in secondary stroke prevention

被引：3
|
作者：
Worrall B.B. [1 ]
Johnston K.C. [1 ]
机构：
[1] Department of Neurology, University of Virginia Health Systems #394, Charlottesville, 22908, VA
来源：
Current Atherosclerosis Reports | 2000年 / 2卷 / 2期
关键词：
Antiplatelet Therapy; Aspirin; Clopidogrel; Dipyridamole; Ischemic Stroke;
D O I：
10.1007/s11883-000-0103-3
中图分类号：
学科分类号：
摘要：
This article focuses on recent data about the safety and effectiveness of antiplatelet therapies for secondary stroke prevention. Highlights include a discussion of changes in the professional labeling for aspirin and the results of a low- versus high-dose aspirin trial (Aspirin after Carotid Endarterectomy trial). Safety issues regarding aspirin also are considered. Other topics include a review of recent data on thrombotic thrombocytopenic purpura (TTP) associated with ticlopidine and a brief update on clopidogrel. A summary of discussions related to the European Stroke Prevention Study 2 data and Food and Drug Administration consideration of combination dipyridamole/aspirin therapy are presented. © 2000, Current Science Inc.
引用
收藏
页码：104 / 109
页数：5
相关论文
共 50 条
12345